logo

For the Inventor, By the Inventor

Port Moody, Canada

Igor Edmondo Paolo D'Angelo

This inventor holds 10 USPTO granted patents and 4 published patent applications and 5 EPO patents. Top assignees: Zymeworks Inc., Eli Lilly and Company, Zymeworks Bc Inc.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Igor Edmondo Paolo D'Angelo. Retrieved from https://idiyas.com/inventor/igor-edmondo-paolo-d-angelo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Port Moody, CA (2016 - 2022)
  • Anmore, CA (2019 - 2022)

Company Filing History:

goldMedal9 out of 56 
 
Zymeworks Inc.
 patents
silverMedal3 out of 4,517 
 
Eli Lilly and Company
 patents
bronzeMedal1 out of 18 
 
Zymeworks Bc Inc.
 patents
where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12286489 - Modified antigen binding polypeptide constructs and uses thereof (2025-04-29),
2. 11351251 - Anti-PD-L1-anti-TIM-3 bispecific antibodies (2022-06-07),
3. 11306156 - Modified antigen binding polypeptide constructs and uses thereof (2022-04-19),
4. 11248037 - Multivalent heteromultimer scaffold design and constructs (2022-02-15),
5. 11203640 - Checkpoint inhibitor bispecific antibodies (2021-12-21),
6. 10711051 - Multivalent heteromultimer scaffold design and constructs (2020-07-14),
7. 10358479 - Multivalent heteromultimer scaffold design and constructs (2019-07-23),
8. 10279034 - Anti-PD-L1-anti-TIM-3 bispecific antibodies (2019-05-07),
9. 10155803 - Multivalent heteromultimer scaffold design and constructs (2018-12-18),
10. 9388231 - Multivalent heteromultimer scaffold design and constructs (2016-07-12),

Title: Igor Edmondo Paolo D'Angelo: Innovator in Biopharmaceuticals

Introduction

Igor Edmondo Paolo D'Angelo is a prominent inventor based in Port Moody, Canada. He has made significant contributions to the field of biopharmaceuticals, holding a total of nine patents. His work primarily focuses on developing innovative therapeutic solutions for cancer treatment.

Latest Patents

Among his latest patents is the invention of Anti-PD-L1-anti-TIM-3 bispecific antibodies. This invention relates to heterodimeric antibodies that bind to human PD-L1 and human TIM-3, potentially offering new avenues for cancer treatment, both alone and in combination with chemotherapy and other cancer therapeutics. Another notable patent is for modified antigen binding polypeptide constructs. This invention provides heterodimer pairs that include immunoglobulin heavy and light chains, with specific amino acid modifications to enhance preferential pairing, thereby improving therapeutic efficacy.

Career Highlights

Igor has worked with notable companies in the biopharmaceutical sector, including Zymeworks Inc. and Eli Lilly and Company. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.

Collaborations

Igor has collaborated with esteemed colleagues such as Surjit Bhimarao Dixit and Mario Sanches. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Igor Edmondo Paolo D'Angelo stands out as an influential inventor in the biopharmaceutical industry. His innovative patents and collaborations reflect his commitment to advancing cancer treatment through scientific research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…